S1900J: A Phase II Study of Amivantamab SC (subcutaneous) in Participants with MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNGMAP Sub-Study)
- Title
- A Phase II Study of Amivantamab SC (subcutaneous) in Participants with MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNGMAP Sub-Study)
- Principal Investigator
- Almubarak, Mohammed
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Lung Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Rachel Harper
- Clinical Research Specialist
- Phone: +1 304-293-6066
- Email: rachel.harper@hsc.wvu.edu